Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome

Clinical trial NCT01160770 · COMPLETED

Trial details

NCT number: NCT01160770
Sponsor: Lundbeck LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lennox-Gastaut Syndrome

Start date: 2005-12-01
Primary completion: 2012-02-01
Enrollment: 267

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.